Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Ocera Therapeutics (OCRX)

1.09 +0.06 (+5.83%)

6/26/2017  4:00pm

Open:

1.03

Pre. Close:

1.03

High:

1.12

Low:

1.00

Volume:

362,769

Market Cap:

28.90M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.15 - 1.16

1.16 - 1.18

Low:

0.94 - 0.96

0.96 - 0.99

Close:

1.05 - 1.08

1.08 - 1.12

Technical analysis  (as of: 2017-06-26 11:35:28 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 1.45     One year: 1.69

Support:

Support1: 1.05    Support2: 0.93

Resistance:

Resistance1: 1.24    Resistance2: 1.45

Pivot:

1.02

Moving Averages:

MA(5): 1.03     MA(20): 1.04

MA(100): 1.07     MA(250): 1.84

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 41.74     %D(3): 31.10

RSI:

RSI(14): 52.69

52-Week:

High: 3.15  Low: 0.52  Change(%): -46.6

Average Vol(K):

3-Month: 532  10-Days 241

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OCRX has closed below upper band by 15.8%. Bollinger Bands are 70% narrower than normal. The narrow width of the bands suggests low volatility as compared to OCRX's normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 10 Mar 2017 22:07:30 GMT
Ocera Therapeutics: Major Risk, Great Upside Potential

Tue, 09 May 2017 20:19:01 GMT
Ocera Therapeutics Reports First Quarter 2017 Financial Results and Provides ...

Tue, 18 Apr 2017 01:30:00 GMT
BRIEF-Perceptive Advisors reports 9.11 pct passive stake in Ocera Therapeutics

Sat, 13 May 2017 09:45:00 GMT
Ocera Therapeutics' (OCRX) CEO Linda Grais on Q1 2017 Results - Earnings Call ...

Mon, 27 Mar 2017 20:05:41 GMT
Ocera to Present at the 16th Annual Needham Healthcare Conference

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

26.51

Shares Float (M)

19.01

% Held by Insiders

41.36

% Held by Institutions

29.90

Shares Short (K)

1380

Shares Short Prior Month (K)

1610

Stock Financials

EPS

-1.150

EPS Est. Current Year

-1.100

EPS Est. Next Year

-1.090

EPS Est. Next Quarter

-0.240

Forward EPS

-1.086

Book Value (p.s.)

0.520

PEG Ratio

Profit Margin

Operating Margin

-4347.22

Return on Assets (ttm)

-46.2

Return on Equity (ttm)

-129.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.023

Sales Per Share

EBITDA (p.s.)

-0.943

Qtrly Earnings Growth

Operating Cash Flow (M)

-23.30

Levered Free Cash Flow (M)

-13.61

FoxReading.com

Valuation

P/E

-0.95

P/E Growth Ratio

0.06

P/BV

2.10

P/S

963196672.00

P/CF

-1.24

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-07-16

Last Split Ratio

0.083

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.